Indiatimes.com -- Ranbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the development said. While the identity of the company could not be ascertained, one of persons said the Bangalore-based company is small in size and the deal could be valued around Rs 50 crore.
